Contact
searchSearch
HMP Global

Psoriatic Arthritis Topic Center

Featured

psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Integrated PsA Screening Framework Improves Outcomes in Dermatology Clinics
08/14/2025
Jessica Garlewicz
The study highlights a scalable clinical model that integrates validated screening tools into routine dermatologic care.
The study highlights a scalable clinical model that integrates validated screening tools into routine dermatologic care.
The study highlights a scalable...
08/14/2025
The Dermatologist
psoriatic arthritis
News
Study Finds Higher Fertility Rates Among Men With Inflammatory Joint Disease
08/14/2025
Jessica Garlewicz
A nationwide cohort study from Norway challenges assumptions about reproductive health in men with inflammatory joint diseases.
A nationwide cohort study from Norway challenges assumptions about reproductive health in men with inflammatory joint diseases.
A nationwide cohort study from...
08/14/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis
06/17/2025
Jessica Garlewicz
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk...
06/17/2025
The Dermatologist
psoriatic arthritis
News
Emerging Imaging Technologies Offer New Precision in Psoriatic Arthritis Diagnosis and Management
06/03/2025
Jessica Garlewicz
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have...
06/03/2025
The Dermatologist
psoriatic arthritis
News
Proteomic Advances Highlight Promising Biomarkers for Psoriatic Arthritis Diagnosis
05/20/2025
Jessica Garlewicz
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the...
05/20/2025
The Dermatologist
psoriatic arthritis
News
Emerging Psoriasis and Psoriatic Arthritis Therapies Expand Treatment Landscape
04/29/2025
Jessica Garlewicz
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the...
04/29/2025
The Dermatologist
psoriatic arthritis
News
Updated Evidence Reinforces Efficacy and Safety of Pharmacologic Therapies in Psoriatic Arthritis
04/17/2025
Jessica Garlewicz
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature...
04/17/2025
The Dermatologist

Expert Insights

Celia Mead, Executive Director of BIRD
Q&As
Bath Institute for Rheumatic Diseases: Empowering Psoriatic Arthritis Researchers and Patients Alike
01/11/2022
Celia Mead
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director...
01/11/2022
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
part 2
Videos
Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata
09/08/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of...
09/08/2025
The Dermatologist
Dr Omid Hamid
Videos
Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results
08/15/2025
Omid Hamid, MD
08/15/2025
The Dermatologist
Glynis Ablon, MD, and Neil Sadick, MD presenters
Videos
Expert Perspectives: Hair Loss Management in Dermatology Practice
08/08/2025
Neil S. Sadick, MD, FAAD; Glynis Ablon
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the...
08/08/2025
The Dermatologist
Part 1 roundtable
Q&As
Part 1: Understanding the Emotional and Physical Toll of Alopecia Areata
08/04/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful...
08/04/2025
The Dermatologist
George Murakawa
Videos
Infusion Therapy for Non-Melanoma Skin Cancer: A Dermatologist’s Guide
07/31/2025
George J. Murakawa, MD, PhD
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology...
07/31/2025
The Dermatologist
Expert Roundtable
Videos
Part 1: The Emotional and Physical Toll of Severe Alopecia Areata
07/21/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this expert roundtable, Drs Brittany Craiglow, Brett King, and Maryanne Senna discuss the emotional and psychosocial weight patients carry—and how clinicians can meet their needs with empathy and understanding.
In this expert roundtable, Drs Brittany Craiglow, Brett King, and Maryanne Senna discuss the emotional and psychosocial weight patients carry—and how clinicians can meet their needs with empathy and understanding.
In this expert roundtable, Drs...
07/21/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Elderderm: Episode 5, Deep and Dutiful Dialogues About Down Below
07/10/2025
Adam Friedman, MD
Dr Emily Murphy joins ElderDerm for a focused discussion on vulvar dermatoses in older adults.
Dr Emily Murphy joins ElderDerm for a focused discussion on vulvar dermatoses in older adults.
Dr Emily Murphy joins ElderDerm...
07/10/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
nahid vidal
Videos
Mohs Surgery for Anogenital and Perineal Tumors: Expert Insights
07/08/2025
Nahid Y. Vidal, MD, FAAD
In this video, Dr Nahid Vidal delves into the complexities of managing anogenital tumors with Mohs surgery.
In this video, Dr Nahid Vidal delves into the complexities of managing anogenital tumors with Mohs surgery.
In this video, Dr Nahid Vidal...
07/08/2025
The Dermatologist

News

psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis
06/17/2025
Jessica Garlewicz
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk...
06/17/2025
The Dermatologist
psoriatic arthritis
News
Emerging Imaging Technologies Offer New Precision in Psoriatic Arthritis Diagnosis and Management
06/03/2025
Jessica Garlewicz
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have...
06/03/2025
The Dermatologist
psoriatic arthritis
News
Proteomic Advances Highlight Promising Biomarkers for Psoriatic Arthritis Diagnosis
05/20/2025
Jessica Garlewicz
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the...
05/20/2025
The Dermatologist
psoriatic arthritis
News
Emerging Psoriasis and Psoriatic Arthritis Therapies Expand Treatment Landscape
04/29/2025
Jessica Garlewicz
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the...
04/29/2025
The Dermatologist
psoriatic arthritis
News
Updated Evidence Reinforces Efficacy and Safety of Pharmacologic Therapies in Psoriatic Arthritis
04/17/2025
Jessica Garlewicz
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature...
04/17/2025
The Dermatologist
psoriatic arthritis
News
New Meta-Review Highlights Prevalence and Psychological Burden of Psoriatic Arthritis
04/01/2025
Jessica Garlewicz
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic...
04/01/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriasis
News
Early Use of Biologics in Psoriasis May Alter Inflammatory Course, Improve Comorbidities
07/10/2025
Jessica Garlewicz
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist

Quiz

Patient with psoriasis and obesity. The effects of obesity can have a negative impact psoriasis and psoriatic arthritis.
Quiz
Trivia: Psoriatic Arthritis and Obesity
10/26/2021
Which of these options best describes the effects of obesity on patients with psoriatic arthritis?
Which of these options best describes the effects of obesity on patients with psoriatic arthritis?
Which of these options best...
10/26/2021
The Dermatologist
Patient with severe psoriasis on knees with a potential link to psoriatic arthritis and its differing oxylipin profile.
Quiz
Trivia: Oxylipin Profiles in PsA versus Psoriasis
09/16/2021
Can you identify the serum oxylipin profiles in patients with psoriatic arthritis and with psoriasis?
Can you identify the serum oxylipin profiles in patients with psoriatic arthritis and with psoriasis?
Can you identify the serum...
09/16/2021
The Dermatologist
Patient with severe psoriasis on their legs shares a risk factor and one inverse association with psoriatic arthritis.
Quiz
Trivia: Risk Factor and Inverse Association Between PsA, PsO, RA and AS
09/02/2021
Which of these options accurately identifies the one risk factor and one inverse association between psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis?
Which of these options accurately identifies the one risk factor and one inverse association between psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis?
Which of these options...
09/02/2021
The Dermatologist
Psoriasis on an elbow with the potential link to psoriatic arthritis showcasing the possibilities of psoriatic treatment.
Quiz
Trivia: Psoriatic Arthritis Risk With Skin Biologics
08/18/2021
Can you determine if the statement on psoriatic arthritis risks with skin biologics is true or false based on a study from Annals of the Rheumatic Diseases?
Can you determine if the statement on psoriatic arthritis risks with skin biologics is true or false based on a study from Annals of the Rheumatic Diseases?
Can you determine if the...
08/18/2021
The Dermatologist
Quiz
Trivia: Air Pollution and Chronic Inflammatory Arthritides
07/13/2021
Can you identify which of the following accurately showcases the results of a study aimed to determine the role of air pollutants on the biological treatment response of chronic inflammatory arthritides?
Can you identify which of the following accurately showcases the results of a study aimed to determine the role of air pollutants on the biological treatment response of chronic inflammatory arthritides?
Can you identify which of the...
07/13/2021
The Dermatologist
True or False: High BMI Association with PsA
Quiz
True or False: High BMI Association with PsA
05/11/2021
Can you determine if the statement regarding BMI association with PsA is true or false?
Can you determine if the statement regarding BMI association with PsA is true or false?
Can you determine if the...
05/11/2021
The Dermatologist
Relationship Between Adalimumab and Psoriatic Arthritis
Quiz
Relationship Between Adalimumab and Psoriatic Arthritis
04/07/2021
What is the relationship between adalimumab and disease activity in patients with psoriatic disease?
What is the relationship between adalimumab and disease activity in patients with psoriatic disease?
What is the relationship between...
04/07/2021
The Dermatologist
Psoriatic Arthritis Diagnosis Delay
Quiz
Psoriatic Arthritis Diagnosis Delay
03/09/2021
Can you identify the patient group that is more susceptible to a delayed diagnosis for psoriatic arthritis?
Can you identify the patient group that is more susceptible to a delayed diagnosis for psoriatic arthritis?
Can you identify the patient...
03/09/2021
The Dermatologist
acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis
06/17/2025
Jessica Garlewicz
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk...
06/17/2025
The Dermatologist
psoriatic arthritis
News
Emerging Imaging Technologies Offer New Precision in Psoriatic Arthritis Diagnosis and Management
06/03/2025
Jessica Garlewicz
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have...
06/03/2025
The Dermatologist
psoriatic arthritis
News
Proteomic Advances Highlight Promising Biomarkers for Psoriatic Arthritis Diagnosis
05/20/2025
Jessica Garlewicz
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the...
05/20/2025
The Dermatologist
psoriatic arthritis
News
Emerging Psoriasis and Psoriatic Arthritis Therapies Expand Treatment Landscape
04/29/2025
Jessica Garlewicz
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the...
04/29/2025
The Dermatologist
psoriatic arthritis
News
Updated Evidence Reinforces Efficacy and Safety of Pharmacologic Therapies in Psoriatic Arthritis
04/17/2025
Jessica Garlewicz
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature...
04/17/2025
The Dermatologist
psoriatic arthritis
News
New Meta-Review Highlights Prevalence and Psychological Burden of Psoriatic Arthritis
04/01/2025
Jessica Garlewicz
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic...
04/01/2025
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use